Article: article from journal or magazin.
Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires.
Publication types: Journal Article ; Research Support, Non-U.S. Gov't - Publication Status: ppublish
HLA-A2+ melanoma patients develop naturally a strong CD8+ T cell response to a self-peptide derived from Melan-A. Here, we have used HLA-A2/peptide tetramers to isolate Melan-A-specific T cells from tumor-infiltrated lymph nodes of two HLA-A2+ melanoma patients and analyzed their TCR beta chain V segment and complementarity determining region 3 length and sequence. We found a broad diversity in Melan-A-specific immune T-cell receptor (TCR) repertoires in terms of both TCR beta chain variable gene segment usage and clonal composition. In addition, immune TCR repertoires selected in the patients were not overlapping. In contrast to previously characterized CD8+ T-cell responses to viral infections, this study provides evidence against usage of highly restricted TCR repertoire in the natural response to a self-differentiation tumor antigen.
Amino Acid Sequence, Antigens, Neoplasm, Base Sequence, Complementarity Determining Regions, Epitopes, T-Lymphocyte, HLA-A2 Antigen, Humans, Immunodominant Epitopes, Immunoglobulin Variable Region, Lymph Nodes, Melanoma, Molecular Sequence Data, Neoplasm Proteins, Peptide Fragments, Receptors, Antigen, T-Cell, alpha-beta, T-Lymphocytes, Cytotoxic
Web of science
Last modification date